140 related articles for article (PubMed ID: 6509865)
1. Can patients be asked to pay for experimental treatment?
Lind SE
Clin Res; 1984 Oct; 32(4):393-8. PubMed ID: 6509865
[No Abstract] [Full Text] [Related]
2. What's the price of a research subject? Approaches to payment for research participation.
Dickert N; Grady C
N Engl J Med; 1999 Jul; 341(3):198-203. PubMed ID: 10403861
[No Abstract] [Full Text] [Related]
3. Physicians, finder's fees and free, informed consent.
Flegel KM
CMAJ; 1997 Nov; 157(10):1373-4. PubMed ID: 9371067
[No Abstract] [Full Text] [Related]
4. Making research a requirement of treatment: why we should sometimes let doctors pressure patients to participate in research.
Orentlicher D
Hastings Cent Rep; 2005; 35(5):20-8. PubMed ID: 16295261
[TBL] [Abstract][Full Text] [Related]
5. Dying children and medical research: access to clinical trials as benefit and burden.
Oberman M; Frader J
Am J Law Med; 2003; 29(2-3):301-17. PubMed ID: 12961809
[No Abstract] [Full Text] [Related]
6. Justice and research design: the case for a semi-randomization clinical trial.
Veatch RM
Clin Res; 1983 Feb; 31(1):12-22. PubMed ID: 10299203
[No Abstract] [Full Text] [Related]
7. Hope and the limits of research.
Daugherty CK; Geller G
Hastings Cent Rep; 1996; 26(5):20; discussion 20-2. PubMed ID: 8891704
[No Abstract] [Full Text] [Related]
8. Subject selection for clinical trials.
American Medical Association. Council on Ethical and Judicial Affairs
IRB; 1998; 20(2-3):12-5. PubMed ID: 11656913
[No Abstract] [Full Text] [Related]
9. Ethical issues in cancer clinical trials.
Kardinal CG
J La State Med Soc; 1994 Aug; 146(8):359-61. PubMed ID: 7930868
[TBL] [Abstract][Full Text] [Related]
10. Research ethics.
Aarons D
West Indian Med J; 1995 Dec; 44(4):115-8. PubMed ID: 8838046
[TBL] [Abstract][Full Text] [Related]
11. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
12. Phase I cancer trials. A collusion of misunderstanding.
Miller M
Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892
[No Abstract] [Full Text] [Related]
13. Abusing the bodies and minds of prisoners: how they are turned into guinea pigs without their knowledge.
Benfell C
Barrister; 1977; 4(2):22-25+. PubMed ID: 11664775
[No Abstract] [Full Text] [Related]
14. The clinical-trials bottleneck.
Russo F
Atl Mon; 1999 May; 283(5):30, 32, 34, 36. PubMed ID: 11657639
[No Abstract] [Full Text] [Related]
15. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
16. The paradoxical case of payment as benefit to research subjects.
Macklin R
IRB; 1989; 11(6):1-3. PubMed ID: 11650284
[No Abstract] [Full Text] [Related]
17. Selling experiment treatment.
Oldham RK
Hastings Cent Rep; 1990; 20(6):43-4. PubMed ID: 2283290
[No Abstract] [Full Text] [Related]
18. Do medical student research subjects need special protection?
Christakis N
IRB; 1985; 7(3):1-4. PubMed ID: 11649647
[No Abstract] [Full Text] [Related]
19. An application of moral guidelines in human clinical trials to a study of a benzodiazepine compound as a hypnotic agent among the elderly.
Axelsen D; Wiggins RA
Clin Res; 1977 Jan; 25(1):1-7. PubMed ID: 10314392
[No Abstract] [Full Text] [Related]
20. The patient as partner: ethics in clinical oncology research.
Veatch RM
Johns Hopkins Med J; 1982 Oct; 151(4):155-61. PubMed ID: 7120718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
